The Multiple Sclerosis Society-UK, says cancer should not receive special funding

Laura Weir, head of policy and campaigns at the MS Society, said the UK government’s flagship Cancer Drugs Fund – which injects an extra £200 million a year to subsidise drugs in England either awaiting or not recommended by NICE – was unfair to patients with other diseases.

She said: “It is estimated that the Cancer Drugs Fund will displace £480 million from other patients in the NHS – is this a fair use of resources to help drive forward the uptake of innovative medicines across other disease areas – I don’t think it is.”